Chemours Co Stock Performance
| CC Stock | USD 15.69 0.06 0.38% |
On a scale of 0 to 100, Chemours holds a performance score of 6. The firm shows a Beta (market volatility) of 2.63, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Chemours will likely underperform. Please check Chemours' semi deviation, jensen alpha, maximum drawdown, as well as the relationship between the coefficient of variation and sortino ratio , to make a quick decision on whether Chemours' price patterns will revert.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Chemours Co are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain fundamental indicators, Chemours exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (1.81) | Five Day Return 5 | Year To Date Return 28.57 | Ten Year Return 351.29 | All Time Return (24.46) |
Forward Dividend Yield 0.0222 | Payout Ratio | Forward Dividend Rate 0.35 | Dividend Date 2025-12-15 | Ex Dividend Date 2025-11-14 |
1 | Chemours Decline Means Insider Profits Down To US49k | 11/07/2025 |
2 | Is Chemours Undervalued After Recent Downtrend A Fresh Look at Its Valuation | 11/17/2025 |
3 | How Investors Are Reacting To Chemours Appointing Michael Foley To Lead Titanium Technologies | 12/05/2025 |
| Chemours dividend paid on 15th of December 2025 | 12/15/2025 |
4 | Acquisition by Mather Courtney of 2226 shares of Chemours subject to Rule 16b-3 | 12/31/2025 |
5 | Acquisition by Satterthwaite Livingston of 1298 shares of Chemours subject to Rule 16b-3 | 01/05/2026 |
6 | Assessing Chemours Valuation After PFAS Class-Action Lawsuit Moves Forward in Montana | 01/08/2026 |
7 | FirstComm Launches AscendOne, A Unified UC CC AI Platform Transforming Business Communications | 01/13/2026 |
8 | Glycolic Acid Market is expected to generate a revenue of USD 461.74 Million by 2032, Globally, at 5.73 percent CAGR Verified Market Research | 01/14/2026 |
9 | CC to Sell Former Titanium Dioxide Taiwan Site Land for 360M | 01/16/2026 |
| Begin Period Cash Flow | 1.8 B | |
| Total Cashflows From Investing Activities | -353 M |
Chemours Relative Risk vs. Return Landscape
If you would invest 1,375 in Chemours Co on October 28, 2025 and sell it today you would earn a total of 200.00 from holding Chemours Co or generate 14.55% return on investment over 90 days. Chemours Co is generating 0.2737% of daily returns and assumes 3.2172% volatility on return distribution over the 90 days horizon. Put differently, 28% of stocks are less risky than Chemours on the basis of their historical return distribution, and some 95% of all equities are expected to be superior in generating returns on investments over the next 90 days. Expected Return |
| Risk |
Chemours Target Price Odds to finish over Current Price
The tendency of Chemours Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 15.69 | 90 days | 15.69 | about 1.57 |
Based on a normal probability distribution, the odds of Chemours to move above the current price in 90 days from now is about 1.57 (This Chemours Co probability density function shows the probability of Chemours Stock to fall within a particular range of prices over 90 days) .
Allowing for the 90-day total investment horizon the stock has the beta coefficient of 2.63 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Chemours will likely underperform. Additionally Chemours Co has an alpha of 0.1246, implying that it can generate a 0.12 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Chemours Price Density |
| Price |
Predictive Modules for Chemours
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Chemours. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Chemours' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Chemours Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Chemours is not an exception. The market had few large corrections towards the Chemours' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Chemours Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Chemours within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.12 | |
β | Beta against Dow Jones | 2.63 | |
σ | Overall volatility | 1.31 | |
Ir | Information ratio | 0.08 |
Chemours Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Chemours for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Chemours can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Chemours had very high historical volatility over the last 90 days | |
| Chemours Co reports about 713 M in cash with (633 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.73. | |
| Chemours has a poor financial position based on the latest SEC disclosures | |
| Over 95.0% of the company shares are held by institutions such as insurance companies | |
| On 15th of December 2025 Chemours paid $ 0.0875 per share dividend to its current shareholders | |
| Latest headline from zacks.com: CC to Sell Former Titanium Dioxide Taiwan Site Land for 360M |
Chemours Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Chemours Stock often depends not only on the future outlook of the current and potential Chemours' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Chemours' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 150 M | |
| Cash And Short Term Investments | 713 M |
Chemours Fundamentals Growth
Chemours Stock prices reflect investors' perceptions of the future prospects and financial health of Chemours, and Chemours fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Chemours Stock performance.
| Return On Equity | -0.67 | |||
| Return On Asset | 0.0283 | |||
| Profit Margin | (0.05) % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 6.16 B | |||
| Shares Outstanding | 149.89 M | |||
| Price To Earning | 25.49 X | |||
| Price To Book | 7.92 X | |||
| Price To Sales | 0.40 X | |||
| Revenue | 5.78 B | |||
| Gross Profit | 1.02 B | |||
| EBITDA | 692 M | |||
| Net Income | 86 M | |||
| Cash And Equivalents | 713 M | |||
| Cash Per Share | 7.73 X | |||
| Total Debt | 4.36 B | |||
| Debt To Equity | 2.94 % | |||
| Current Ratio | 1.82 X | |||
| Book Value Per Share | 1.99 X | |||
| Cash Flow From Operations | (633 M) | |||
| Earnings Per Share | (2.13) X | |||
| Market Capitalization | 2.36 B | |||
| Total Asset | 7.51 B | |||
| Retained Earnings | 1.72 B | |||
| Working Capital | 1.22 B | |||
| Current Asset | 2.3 B | |||
| Current Liabilities | 1.47 B | |||
About Chemours Performance
By analyzing Chemours' fundamental ratios, stakeholders can gain valuable insights into Chemours' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Chemours has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Chemours has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 104.42 | 67.65 | |
| Return On Tangible Assets | 0.01 | 0.01 | |
| Return On Capital Employed | 0.09 | 0.13 | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | 0.13 | 0.18 |
Things to note about Chemours performance evaluation
Checking the ongoing alerts about Chemours for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Chemours help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Chemours had very high historical volatility over the last 90 days | |
| Chemours Co reports about 713 M in cash with (633 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.73. | |
| Chemours has a poor financial position based on the latest SEC disclosures | |
| Over 95.0% of the company shares are held by institutions such as insurance companies | |
| On 15th of December 2025 Chemours paid $ 0.0875 per share dividend to its current shareholders | |
| Latest headline from zacks.com: CC to Sell Former Titanium Dioxide Taiwan Site Land for 360M |
- Analyzing Chemours' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Chemours' stock is overvalued or undervalued compared to its peers.
- Examining Chemours' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Chemours' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Chemours' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Chemours' stock. These opinions can provide insight into Chemours' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Global Correlations Find global opportunities by holding instruments from different markets |